Methods of inhibiting orthopoxvirus replication with nucleoside compounds

Details for Australian Patent Application No. 2003209045 (hide)

International Classifications

Event Publications

17 July 2003 Complete Application Filed

Priority application(s): 60/356,805 13.02.02 US

2 October 2003 Application Open to Public Inspection

Published as AU-B-2003209045

14 December 2006 Application Accepted

Published as AU-B-2003209045

19 April 2007 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend the co-patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

The name of the patentee has been altered to Isis Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.